Search results for "bioplan"
Article
Bioprocessing Advances in Vaccine Manufacture
According to BioPlan's recently released analysis of 10-year industry trends (1), a confluence of technological advances in bioprocessing is making vaccine manufacture cheaper, faster, and simpler. Th…
Article
Automation Trend in Fill/Finish Reduces Contamination Risk
…d cost efficiency are not compromised at the critical, late-stage fill/finish process, according to BioPlan Associates’ 14th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and P…
Article
Managing Biomanufacturing Capacity Expectations
According to a new survey by BioPlan Associates, more than half of respondents (60%) expect facility constraints to create biopharmaceutical production capacity constraints by 2021 (1). BioPlan found …
Article
Downstream Processing Continues to Worry CMOs
…(CMOs), and downstream-fueled bottlenecks don’t appear to show any signs of abating, according to BioPlan Associates 13th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Prod…
Article
CMOs Concerned With Cost of Single-Use Equipment
In fact, according to the latest industry study from BioPlan Associates (1), there appears to be one aspect of single-use application that CMOs feel is inhibiting adoption: The cost.
As part of th…
Article
A Plastic Pipeline for Commercial Bioprocessing?
Most respondents to a BioPlan Associates survey (3) noted that less than 50% of their commercial manufacturing operations incorporated single-use components or devices; the most frequent response was …
Article
State of the Biopharmaceutical Industry: Lessons from 2018 Survey Data
Langer, managing partner at BioPlan Associates, Inc., talks with the Process Development Forum about the 2018 survey, the 15th in their annual look at the state of the manufacturing industry.
Wh…
Article
The New World of Biopharmaceutical Manufacturing
…le-use systems for biopharmaceutical manufacturing in the past 40 years?
Langer (BioPlan Associates): Over the past 40 years, single-use systems have moved from simple blood and intrave…
Article
Continuous Manufacturing: A Changing Processing Paradigm
While only a few approved biologic products in the market—less than 10%, according to estimates by Eric Langer, managing partner, BioPlan Associates—are manufactured through perfusion or continuous do…
Article
Q&As with Industry Leaders
…m 2018 Survey Data
Eric Langer, President and Managing Partner at BioPlan Associates
Establishment of New…